Literature DB >> 25432536

Fragile X-like behaviors and abnormal cortical dendritic spines in cytoplasmic FMR1-interacting protein 2-mutant mice.

Kihoon Han1, Hogmei Chen2, Vincenzo A Gennarino3, Ronald Richman4, Hui-Chen Lu5, Huda Y Zoghbi6.   

Abstract

Silencing of fragile X mental retardation 1 (FMR1) gene and loss of fragile X mental retardation protein (FMRP) cause fragile X syndrome (FXS), a genetic disorder characterized by intellectual disability and autistic behaviors. FMRP is an mRNA-binding protein regulating neuronal translation of target mRNAs. Abnormalities in actin-rich dendritic spines are major neuronal features in FXS, but the molecular mechanism and identity of FMRP targets mediating this phenotype remain largely unknown. Cytoplasmic FMR1-interacting protein 2 (Cyfip2) was identified as an interactor of FMRP, and its mRNA is a highly ranked FMRP target in mouse brain. Importantly, Cyfip2 is a component of WAVE regulatory complex, a key regulator of actin cytoskeleton, suggesting that Cyfip2 could be implicated in the dendritic spine phenotype of FXS. Here, we generated and characterized Cyfip2-mutant (Cyfip2(+/-)) mice. We found that Cyfip2(+/-) mice exhibited behavioral phenotypes similar to Fmr1-null (Fmr1(-/y)) mice, an animal model of FXS. Synaptic plasticity and dendritic spines were normal in Cyfip2(+/-) hippocampus. However, dendritic spines were altered in Cyfip2(+/-) cortex, and the dendritic spine phenotype of Fmr1(-/y) cortex was aggravated in Fmr1(-/y); Cyfip2(+/-) double-mutant mice. In addition to the spine changes at basal state, metabotropic glutamate receptor (mGluR)-induced dendritic spine regulation was impaired in both Fmr1(-/y) and Cyfip2(+/-) cortical neurons. Mechanistically, mGluR activation induced mRNA translation-dependent increase of Cyfip2 in wild-type cortical neurons, but not in Fmr1(-/y) or Cyfip2(+/-) neurons. These results suggest that misregulation of Cyfip2 function and its mGluR-induced expression contribute to the neurobehavioral phenotypes of FXS.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25432536      PMCID: PMC4355018          DOI: 10.1093/hmg/ddu595

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  47 in total

1.  Enhancements and modifications of primer design program Primer3.

Authors:  Triinu Koressaar; Maido Remm
Journal:  Bioinformatics       Date:  2007-03-22       Impact factor: 6.937

Review 2.  Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function.

Authors:  Gary J Bassell; Stephen T Warren
Journal:  Neuron       Date:  2008-10-23       Impact factor: 17.173

Review 3.  Molecular mechanisms of fragile X syndrome: a twenty-year perspective.

Authors:  Michael R Santoro; Steven M Bray; Stephen T Warren
Journal:  Annu Rev Pathol       Date:  2011-10-10       Impact factor: 23.472

4.  Human-specific regulation of MeCP2 levels in fetal brains by microRNA miR-483-5p.

Authors:  Kihoon Han; Vincenzo Alessandro Gennarino; Yoontae Lee; Kaifang Pang; Kazue Hashimoto-Torii; Sanaa Choufani; Chandrasekhar S Raju; Michael C Oldham; Rosanna Weksberg; Pasko Rakic; Zhandong Liu; Huda Y Zoghbi
Journal:  Genes Dev       Date:  2013-02-21       Impact factor: 11.361

5.  Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits.

Authors:  T A Comery; J B Harris; P J Willems; B A Oostra; S A Irwin; I J Weiler; W T Greenough
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

Review 6.  Which comes first in fragile X syndrome, dendritic spine dysgenesis or defects in circuit plasticity?

Authors:  Carlos Portera-Cailliau
Journal:  Neuroscientist       Date:  2011-05-06       Impact factor: 7.519

7.  Metabotropic receptor-dependent long-term depression persists in the absence of protein synthesis in the mouse model of fragile X syndrome.

Authors:  Elena D Nosyreva; Kimberly M Huber
Journal:  J Neurophysiol       Date:  2006-02-01       Impact factor: 2.714

8.  Phosphorylation of WAVE1 regulates actin polymerization and dendritic spine morphology.

Authors:  Yong Kim; Jee Young Sung; Ilaria Ceglia; Ko-Woon Lee; Jung-Hyuck Ahn; Jonathan M Halford; Amie M Kim; Seung P Kwak; Jong Bae Park; Sung Ho Ryu; Annette Schenck; Barbara Bardoni; John D Scott; Angus C Nairn; Paul Greengard
Journal:  Nature       Date:  2006-07-16       Impact factor: 49.962

9.  Genetic removal of p70 S6 kinase 1 corrects molecular, synaptic, and behavioral phenotypes in fragile X syndrome mice.

Authors:  Aditi Bhattacharya; Hanoch Kaphzan; Amanda C Alvarez-Dieppa; Jaclyn P Murphy; Philippe Pierre; Eric Klann
Journal:  Neuron       Date:  2012-10-17       Impact factor: 17.173

10.  The fragile X syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BP.

Authors:  Ilaria Napoli; Valentina Mercaldo; Pietro Pilo Boyl; Boris Eleuteri; Francesca Zalfa; Silvia De Rubeis; Daniele Di Marino; Evita Mohr; Marzia Massimi; Mattia Falconi; Walter Witke; Mauro Costa-Mattioli; Nahum Sonenberg; Tilmann Achsel; Claudia Bagni
Journal:  Cell       Date:  2008-09-19       Impact factor: 41.582

View more
  27 in total

1.  Novel West syndrome candidate genes in a Chinese cohort.

Authors:  Jing Peng; Ying Wang; Fang He; Chen Chen; Li-Wen Wu; Li-Fen Yang; Yu-Ping Ma; Wen Zhang; Zi-Qing Shi; Chao Chen; Kun Xia; Hui Guo; Fei Yin; Nan Pang
Journal:  CNS Neurosci Ther       Date:  2018-04-17       Impact factor: 5.243

2.  Cell-type-specific metabolic labeling of nascent proteomes in vivo.

Authors:  Beatriz Alvarez-Castelao; Christoph T Schanzenbächer; Cyril Hanus; Caspar Glock; Susanne Tom Dieck; Aline R Dörrbaum; Ina Bartnik; Belquis Nassim-Assir; Elena Ciirdaeva; Anke Mueller; Daniela C Dieterich; David A Tirrell; Julian D Langer; Erin M Schuman
Journal:  Nat Biotechnol       Date:  2017-11-06       Impact factor: 54.908

3.  Spatially clustering de novo variants in CYFIP2, encoding the cytoplasmic FMRP interacting protein 2, cause intellectual disability and seizures.

Authors:  Markus Zweier; Anaïs Begemann; Kirsty McWalter; Megan T Cho; Lucia Abela; Siddharth Banka; Bettina Behring; Andrea Berger; Chester W Brown; Maryline Carneiro; Jiani Chen; Gregory M Cooper; Candice R Finnila; Maria J Guillen Sacoto; Alex Henderson; Ulrike Hüffmeier; Pascal Joset; Bronwyn Kerr; Gaetan Lesca; Gloria S Leszinski; John Henry McDermott; Meira R Meltzer; Kristin G Monaghan; Roya Mostafavi; Katrin Õunap; Barbara Plecko; Zöe Powis; Gabriela Purcarin; Tiia Reimand; Korbinian M Riedhammer; John M Schreiber; Deepa Sirsi; Klaas J Wierenga; Monica H Wojcik; Sorina M Papuc; Katharina Steindl; Heinrich Sticht; Anita Rauch
Journal:  Eur J Hum Genet       Date:  2019-01-21       Impact factor: 4.246

4.  Cyfip1 Regulates Presynaptic Activity during Development.

Authors:  Kuangfu Hsiao; Hala Harony-Nicolas; Joseph D Buxbaum; Ozlem Bozdagi-Gunal; Deanna L Benson
Journal:  J Neurosci       Date:  2016-02-03       Impact factor: 6.167

5.  Striatal Transcriptome and Interactome Analysis of Shank3-overexpressing Mice Reveals the Connectivity between Shank3 and mTORC1 Signaling.

Authors:  Yeunkum Lee; Sun Gyun Kim; Bokyoung Lee; Yinhua Zhang; Yoonhee Kim; Shinhyun Kim; Eunjoon Kim; Hyojin Kang; Kihoon Han
Journal:  Front Mol Neurosci       Date:  2017-06-28       Impact factor: 5.639

6.  Integrative Analysis of Brain Region-specific Shank3 Interactomes for Understanding the Heterogeneity of Neuronal Pathophysiology Related to SHANK3 Mutations.

Authors:  Yeunkum Lee; Hyojin Kang; Bokyoung Lee; Yinhua Zhang; Yoonhee Kim; Shinhyun Kim; Won-Ki Kim; Kihoon Han
Journal:  Front Mol Neurosci       Date:  2017-04-19       Impact factor: 5.639

Review 7.  Overlapping Molecular Pathways Leading to Autism Spectrum Disorders, Fragile X Syndrome, and Targeted Treatments.

Authors:  Maria Jimena Salcedo-Arellano; Ana Maria Cabal-Herrera; Ruchi Harendra Punatar; Courtney Jessica Clark; Christopher Allen Romney; Randi J Hagerman
Journal:  Neurotherapeutics       Date:  2020-11-19       Impact factor: 7.620

Review 8.  Cytoplasmic FMR1 interacting protein (CYFIP) family members and their function in neural development and disorders.

Authors:  Ísis Venturi Biembengut; Isabelle Leticia Zaboroski Silva; Tatiana de Arruda Campos Brasil de Souza; Patrícia Shigunov
Journal:  Mol Biol Rep       Date:  2021-07-29       Impact factor: 2.316

9.  An integrative approach to investigate the respective roles of single-nucleotide variants and copy-number variants in Attention-Deficit/Hyperactivity Disorder.

Authors:  Leandro de Araújo Lima; Ana Cecília Feio-dos-Santos; Sintia Iole Belangero; Ary Gadelha; Rodrigo Affonseca Bressan; Giovanni Abrahão Salum; Pedro Mario Pan; Tais Silveira Moriyama; Ana Soledade Graeff-Martins; Ana Carina Tamanaha; Pedro Alvarenga; Fernanda Valle Krieger; Bacy Fleitlich-Bilyk; Andrea Parolin Jackowski; Elisa Brietzke; João Ricardo Sato; Guilherme Vanoni Polanczyk; Jair de Jesus Mari; Gisele Gus Manfro; Maria Conceição do Rosário; Eurípedes Constantino Miguel; Renato David Puga; Ana Carolina Tahira; Viviane Neri Souza; Thais Chile; Gisele Rodrigues Gouveia; Sérgio Nery Simões; Xiao Chang; Renata Pellegrino; Lifeng Tian; Joseph T Glessner; Ronaldo Fumio Hashimoto; Luis Augusto Rohde; Patrick M A Sleiman; Hakon Hakonarson; Helena Brentani
Journal:  Sci Rep       Date:  2016-03-07       Impact factor: 4.379

10.  Alzheimer-related decrease in CYFIP2 links amyloid production to tau hyperphosphorylation and memory loss.

Authors:  Sachin Suresh Tiwari; Keiko Mizuno; Anshua Ghosh; Wajeeha Aziz; Claire Troakes; Jason Daoud; Vidushi Golash; Wendy Noble; Tibor Hortobágyi; Karl Peter Giese
Journal:  Brain       Date:  2016-08-14       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.